
© 2025 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
32,800 | 33,800 | 18:40 | |
33,000 | 33,400 | 18:37 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards? | ||
11.04. | Goldman Sachs maintains Neutral on CRISPR Therapeutics stock | ||
11.04. | Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? | ||
04.04. | Crispr Therapeutics gets orphan drug status for lymphoma treatment | ||
04.04. | Crispr Therapeutics erhält Orphan-Drug-Status für Lymphom-Behandlung |